1EDD Hoffman-Censits, Jean - Thomas Jefferson University - Thomas Jefferson University
Dr. Hoffman-Censits

Jean Hoffman-Censits, MD

Contact Dr. Hoffman-Censits

925 Chestnut Street
Suite 220A
Philadelphia, PA 19107

(215) 955-8874

Most Recent Peer-reviewed Publications

  1. Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based chemotherapy in Muscle-invasive Bladder Cancer
  2. Reply to D. Pouessel et al, J.B. Aragon-Ching, and B.A. Adesunloye
  3. Perioperative and Maintenance Therapy after First-Line Therapy as Paradigms for Drug Discovery in Urothelial Carcinoma
  4. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: Results of a multicenter phase II study with molecular correlates of response and toxicity
  5. Practical guide to the use of enzalutamide
  6. Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
  7. Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer: A report from the Bladder Cancer Advocacy Network Clinical Trials Working Group
  8. Chemotherapy and targeted therapies: Are we making progress in castrate-resistant prostate cancer?
  9. Enzalutamide: A novel antiandrogen for patients with castrate-resistant prostate cancer
  10. Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy
  11. A wealth of new options: A case presentation of the management of castration-recurrent prostate cancer
  12. Enhancing prostate cancer care through the multidisciplinary clinic approach: A 15-year experience
  13. Chemotherapy for Penile and Urethral Carcinoma